American pharmaceutical manufacturer, the company Amarin announced the results of clinical trials of their new drug, which has added omega-3-polyunsaturated fatty acids. This medicine for the first time led to a statistically significant reduction in the risk of death from heart attacks and strokes, according to the portal STAT.
The researchers found that the drug reduced mortality by 25%. It is noted that the drug was well tolerated by patients, side effects were recorded.
It is noted that earlier clinical trials of drugs with omega-3 showed a significant reduction in the risk of cardiovascular diseases, therefore, the conclusions of the company’s representatives have yet to be tested.
In July, American scientists from the University of Illinois found that consuming omega-3 fatty acids may prevent cancer and stop its growth and spread.
One of the best sources of omega-3 are fish oil, seafood and flax seeds.